These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7224878)

  • 21. [Invasive properties of follicular adenoma and follicular carcinoma of the thyroid gland].
    Rudkovskiĭ MS; Gurevich GI
    Vestn Khir Im I I Grek; 1988 Jul; 141(7):67-8. PubMed ID: 3222901
    [No Abstract]   [Full Text] [Related]  

  • 22. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular and capsular pseudoinvasion in thyroid neoplasms.
    Chebib I; Opher E; Richardson ME
    Int J Surg Pathol; 2009 Dec; 17(6):449-51. PubMed ID: 19666948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renal metastasis of a metastasizing thyroid adenoma].
    Ramthor W; Müller GW
    Z Urol Nephrol; 1980 Jun; 73(6):427-32. PubMed ID: 7191605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Poorly-differentiated thyroid carcinoma: morphological verification and differential diagnosis].
    Friedman MV
    Vopr Onkol; 2006; 52(1):47-53. PubMed ID: 16715703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computerized nuclear morphometry in thyroid follicular neoplasms.
    Wang SL; Wu MT; Yang SF; Chan HM; Chai CY
    Pathol Int; 2005 Nov; 55(11):703-6. PubMed ID: 16271082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The differential diagnosis of follicular adenomas and carcinomas in fine needle biopsies of the thyroid gland by means of automatic image analysis (author's transl)].
    Schuh D; Steidl R; Voss K
    Zentralbl Allg Pathol; 1980; 124(6):557-60. PubMed ID: 7210935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma.
    Dosen D; Turić M; Smalcelj J; Janusić R; Grgić MP; Separović V
    Head Neck; 2003 Jul; 25(7):521-8. PubMed ID: 12808654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis].
    Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA
    Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A
    Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of the rare thyroid carcinoma which is indistinguishable from a follicular adenoma.
    Blum M; Feiner HD; Worth MH; King LW
    Am J Med Sci; 1978; 276(1):99-104. PubMed ID: 727220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytomorphological and cytochemical studies of experimentally-induced thyroid tumors in the rat].
    Müller P; Hambsch K; Haupt R; Herrmann F; Sorger D
    Zentralbl Pathol; 1991; 137(1):29-34. PubMed ID: 2059608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
    Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
    Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On problems of the term "atypical adenoma" of the thyroid gland (author's transl)].
    Kühne W; Willgeroth C
    Zentralbl Allg Pathol; 1982; 126(1-2):142-50. PubMed ID: 7090593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.